PES Drugs and Therapeutics Committee presents a statement on the Risk of Prolonged QT Interval with Gonadotropin Releasing Hormone Agonists.
Read MoreThe first international consensus statement on diagnosis and management of Silver–Russell syndrome presented by 41 task force members from 16 countries.
Read MoreAn International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children.
Read More